Despite the lack of direct evidence, most review articles suggest that gliadin peptide deamidation by TG2 occurs in the lamina propria since the lamina propria harbors the T cells that drive CeD pathogenesis [1]. This evidence concerns the gene TGM2 and cranioectodermal dysplasia.